These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 25368985)
1. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma. Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985 [TBL] [Abstract][Full Text] [Related]
2. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors. Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251 [TBL] [Abstract][Full Text] [Related]
3. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China. Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257 [TBL] [Abstract][Full Text] [Related]
5. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry. Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC). Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229 [TBL] [Abstract][Full Text] [Related]
7. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS. Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542 [TBL] [Abstract][Full Text] [Related]
8. Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer. Yang J; Xiong X; Wang X; Guo B; He K; Huang C Tumour Biol; 2015 Jul; 36(7):5109-18. PubMed ID: 25677901 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers screening between preoperative and postoperative patients in pancreatic cancer. Li P; Yang J; Ma QY; Wu Z; Huang C; Li XQ; Wang Z Asian Pac J Cancer Prev; 2013; 14(7):4161-5. PubMed ID: 23991970 [TBL] [Abstract][Full Text] [Related]
10. Differential expression and clinical significance of serum protein among patients with clear-cell renal cell carcinoma. Nuerrula Y; Rexiati M; Liu Q; Wang YJ Cancer Biomark; 2015; 15(4):485-91. PubMed ID: 26406868 [TBL] [Abstract][Full Text] [Related]
11. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Zheng N; Pan C; Liu W J Int Med Res; 2011; 39(4):1184-92. PubMed ID: 21986120 [TBL] [Abstract][Full Text] [Related]
12. Screening for the serum differential proteins of renal cell carcinoma using magnetic beads-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Liu JS; Li HZ; Zhang YS; Wang P; Yan WG; Xie J; Dong DX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):287-91. PubMed ID: 21718612 [TBL] [Abstract][Full Text] [Related]
13. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769 [TBL] [Abstract][Full Text] [Related]
14. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades. Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802 [TBL] [Abstract][Full Text] [Related]
15. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry. Shevchenko VE; Arnotskaya NE; Zaridze DG Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202 [TBL] [Abstract][Full Text] [Related]
16. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231 [TBL] [Abstract][Full Text] [Related]
17. SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons. Xu G; Xiang CQ; Lu Y; Wang WJ; Kang XN; Liao P; Ding Q; Zhang YF Technol Cancer Res Treat; 2009 Jun; 8(3):225-30. PubMed ID: 19445540 [TBL] [Abstract][Full Text] [Related]
19. The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma. Zhang F; Ma X; Li H; Guo G; Li P; Li H; Gu L; Li X; Chen L; Zhang X Urol Oncol; 2017 Jun; 35(6):392-400. PubMed ID: 28188089 [TBL] [Abstract][Full Text] [Related]
20. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry. Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]